← back to search

Sébastien G. Gouin

Gene Therapy Laboratory · FR
Area of research
Molecular Biology · Organic Chemistry
Research interest
Research interests include Capsid, Chemistry, Genetic enhancement, Gene delivery, Escherichia coli, and Bioconjugation.
h-index
citations
479
works
15
NIH funding
primary concept
email

Recent publications

Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retina
Biomedicine & Pharmacotherapy 2024cited by 17position: middledoi
Bioorthogonal chemical engineering of rAAV capsid: Advancing gene therapy targeting using proteins
ChemRxiv 2024cited by 3position: middledoi
Advancing Liver Gene Therapy: Enhanced Transduction with GalNAc-Bioconjugated rAAV Capsids
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 0position: middledoi
L’électrochimie-click pour la fonctionnalisation de surfaces virales, bactériennes ou de cellules eucaryotes
médecine/sciences 2024cited by 0position: lastdoi
Click-electrochemistry for the rapid labeling of virus, bacteria and cell surfaces
Nature Communications 2023cited by 44position: lastdoi
Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retina
ChemRxiv 2023cited by 4position: middledoi
Luminol Anchors Improve the Electrochemical-Tyrosine-Click Labelling of Proteins
2021cited by 3position: lastdoi
Chemical modification of the adeno-associated virus capsid to improve gene delivery
Chemical Science 2019cited by 88position: middledoi
Chem-AAV: Chemically Modified AAV for Targeting Gene Delivery
HAL (Le Centre pour la Communication Scientifique Directe) 2018cited by 0position: middle
The potential of FimH as a novel therapeutic target for the treatment of Crohn’s disease
Expert Opinion on Therapeutic Targets 2017cited by 44position: middledoi
Chem-AAV: Chemically Modified AAV for Gene Therapy
HAL (Le Centre pour la Communication Scientifique Directe) 2017cited by 0position: middle
Development of Heptylmannoside-Based Glycoconjugate Antiadhesive Compounds against Adherent-Invasive Escherichia coli Bacteria Associated with Crohn's Disease
mBio 2015cited by 66position: middledoi
Simple but Precise Engineering of Functional Nanocapsules through Nanoprecipitation
Angewandte Chemie International Edition 2014cited by 62position: middledoi
Topological Effects and Binding Modes Operating with Multivalent Iminosugar-Based Glycoclusters and Mannosidases
Journal of the American Chemical Society 2013cited by 84position: lastdoi
Heptyl α‐<scp>D</scp>‐Mannosides Grafted on a β‐Cyclodextrin Core To Interfere with <i>Escherichia coli</i> Adhesion: An In Vivo Multivalent Effect
Chemistry - A European Journal 2013cited by 64position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 11 papers (2013–2024)Mathieu Mével · Gene Therapy Laboratory9 papers (2017–2024)Mohammed Bouzelha · Gene Therapy Laboratory8 papers (2017–2024) · 8 papers (2015–2024) · 7 papers (2021–2024)Oumeya Adjali · Gene Therapy Laboratory6 papers (2018–2024)Eduard Ayuso · Gene Therapy Laboratory6 papers (2017–2024)Mickaël Guilbaud · Translational Research in Gene Therapy5 papers (2019–2024)Maia Marchand · Gene Therapy Laboratory5 papers (2023–2024)Karine Pavageau · Gene Therapy Laboratory5 papers (2023–2024) · 3 papers (2013–2017) · 3 papers (2023–2024) · 3 papers (2023–2024)Julien Bernard · Université Claude Bernard Lyon 13 papers (2014–2017)Mikaël Croyal · Centre National de la Recherche Scientifique3 papers (2021–2024)Tiphaine Girard · Gene Therapy Laboratory3 papers (2023–2024)Caroline Le Guiner · Gene Therapy Laboratory3 papers (2023–2024) · 3 papers (2019–2024)Audrey Bourdon · Gene Therapy Laboratory3 papers (2023–2024) · 3 papers (2023–2024)